isofenphos has been researched along with Atrial Fibrillation in 2 studies
*Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chiu, YD; Fynn, S; Holcombe, HM; Mills, C; Nashef, SAM; Sharples, LD | 1 |
GarcĂa-Villarreal, OA | 1 |
1 trial(s) available for isofenphos and Atrial Fibrillation
Article | Year |
---|---|
Five-year results of Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation.
Topics: Atrial Fibrillation; Catheter Ablation; Humans; Quality of Life; Stroke; Treatment Outcome | 2022 |
1 other study(ies) available for isofenphos and Atrial Fibrillation
Article | Year |
---|---|
The full bi-atrial lesion pattern in the Cox-maze procedure: a concept rather than a technique.
Topics: Atrial Fibrillation; Heart Valve Diseases; Humans; Organothiophosphorus Compounds | 2022 |